Plasmonics-Based COVID-19 Test Delivers Results in POC Settings
NEW YORK, Aug. 17, 2022 — Researchers at Columbia Engineering and Rover Diagnostics, a Columbia Technology Ventures company, used plasmonic nanoparticles with compact optics to develop a real-time, multiplexed, reverse-transcriptase quantitative polymerase chain reaction (RT-qPCR) test. Weighing just two pounds, the ultrafast, portable PCR testing system is practical for use in decentralized and point-of-care (POC) settings. “Our aim was to create a platform that can be used in locations where rapid